August 2017

Hope for families as MSAC delivers

Posted: 4/08/2017 10:09:07 AM

After a decade of lobbying and in response to a Genea submission, the Medical Services Advisory Committee (MSAC) has formally recommended the Federal Government provide funding for pre-implantation genetic diagnosis (PGD).

Media Contact

Alice Ross
M: 0421 741 737
E: alice.ross@genea.com.au

About Genea

Genea is one of Australia’s leading providers for infertility, IVF and other assisted conception treatment with 31 years of experience in the field. The company has long been a fertility pioneer, with research and technologies developed in-house virtually doubling IVF success rates in the mid-nineties and continuing to improve outcomes today. In September 2017, Genea was listed in the Australian Financial Review’s Top 50 Most Innovative Companies List, ranking number 25.

August 2017

Hope for families as MSAC delivers

News Archives

Media Contact

About Genea